{"nct_id":"NCT00272987","title":"ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib","status":"TERMINATED","status_verified_date":"2023-04","start_date":"2005-12-13","start_date_type":"ACTUAL","primary_completion_date":"2009-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2019-10-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}